Morphine-induced cardiogenic shock

Annals of Pharmacotherapy

Volumn 45, Issue 6, 2011, Pages 30-

  Feeney, Colin ^a   Ani, Chizobam ^b   Sharma, Naini ^a   Frohlich, Tom ^a  

^a ALAMEDA COUNTY MEDICAL CENTER   (United States)

^b CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Cardiogenic shock; Heroin; Morphine; Naloxone; Opioid

Indexed keywords

ENALAPRIL; ENOXAPARIN; INFUSION FLUID; IPRATROPIUM BROMIDE PLUS SALBUTAMOL; MORPHINE; NALOXONE; NORADRENALIN; TRIACYLGLYCEROL LIPASE;

ABDOMINAL TENDERNESS; ACUTE PANCREATITIS; ADULT; ARTICLE; CARDIOGENIC SHOCK; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPIGASTRIC PAIN; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INTENSIVE CARE UNIT; PATIENT CONTROLLED ANALGESIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ADULT; ANALGESICS, OPIOID; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NOREPINEPHRINE; SHOCK, CARDIOGENIC; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79958831928     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q022     Document Type: Article

References (34)

1. Miller RD. Opioid analgesics. In: Miller RD, ed. Miller's anesthesia. 7th ed. Philadelphia: Churchill Livingstone, 2009
2. Fonarow GC. Pharmacologic therapies for acutely decompensated heart failure. Cardiovasc Med 2002;3(suppl 4):S18-27.
3. Kato R, Foëx P. Fentanyl reduces infarction but not stunning via deltaopioid receptors and protein kinase C in rats. Br J Anaesth 2000;84:608-14.
4. Kato R, Ross S, Foëx P. Fentanyl protects the heart against ischaemic injury via opioid receptors, adenosine A1 receptors and KATP channel linked mechanisms in rats. Br J Anaesth 2000;84:204-14.
5. Warltier DC, Pagel PS, Kersten JR. Approaches to the prevention of perioperative myocardial ischemia. Anesthesiology 2000;92:253-9.
6. Helman JD, Leung JM, Bellows WH, et al. The risk of myocardial ischemia in patients receiving desflurane versus sufentanil anesthesia for coronary artery bypass graft surgery. The S.P.I. Research Group. Anesthesiology 1992;77:47-62.
7. Leung JM, Goehner P, O'Kelly BF, et al. Isoflurane anesthesia and myocardial ischemia: comparative risk versus sufentanil anesthesia in patients undergoing coronary artery bypass graft surgery. The SPI (Study of Perioperative Ischemia) Research Group. Anesthesiology 1991;74:838-47.
8. Zhang SZ, Wang N, Xu J, et al. Kappa-opioid receptors mediate cardioprotection by remote preconditioning. Anesthesiology 2006;105:550-6.
9. Schultz JE, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996:1100-4.
10. Feldman PD, Parveen N, Sezen S. Cardiovascular effects of Leuenkephalin in the nucleus tractus solitarius of the rat. Brain Res 1996;709:331-6.
11. Keay KA, Crowfoot LJ, Floyd NS, et al. Cardiovascular effects of microinjections of opioid agonists into the 'Depressor Region' of the ventrolateral periaqueductal gray region. Brain Res 1997;762:61-71.
12. Grossmann M, Abiose A, Tangphao O, Blaschke TF, Hoffman BB. Morphine- induced venodilation in humans. Clin Pharmacol Ther 1996; 60:554.
13. Holaday JW, Faden AI. Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock. Nature 1978;275:450-1
14. Llobel F, Laorden ML. Effects of morphine on atrial preparations obtained from nonfailing and failing human hearts. Br J Anaesth 1996;76: 106-10.
15. Hung CF, Tsai CH, Su MJ. Opioid receptor independent effects of morphine on membrane currents in single cardiac myocytes. Br J Anaesth 1998;81:925-31.
16. Kistner J, Miller ED Jr, Lake C, Ross W. Indices of myocardial oxygenation during coronary artery revascularization in man with morphine versus halothane anesthesia. Anesthesiology 1979;50:324-30.
17. Riggs TR, Yano Y, Vargish T. Opiate agonist depression of myocardial function is dose related and independent of pentoobarbital or chloral hydrate anesthesia. Am Surg 1986;52:654-8.
18. Riggs TR, Yano Y, Vargish T. Morphine depression of myocardial function. Circ Shock 1986;19:31-8.
19. Vargish T, Beamer KC, Dlay T, Riggs TR. Morphine sulfate depression of cardiac function is attenuated by opiate receptor antagonism with naloxone. Circ Shock 1987;23:189-95.
20. Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J 2006;27:1523-9.
21. Naranjo C, Busto U, Sellers E, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
22. Darke S, Zador D. Fatal heroin 'overdose': a review. Addiction 1996;91:1765-72.
23. Barke KE, Hough LB. Opiates, mast cells and histamine release. Life Sci 1993;53:1391-9.
24. Sporer KA, Dorn E. Heroin-related noncardiogenic pulmonary edema. Chest 2001;120:1628-32.
25. Karliner JS. Noncardiogenic forms of pulmonary edema. Circulation 1972;46:212-5.
26. Smith WR, Glauser FL, Dearden LC, et al. Deposits of immunoglobulin and complement in the pulmonary tissue of patients with "heroin lung." Chest 1978;73:471-6.
27. Otto D, Franke M, Madden JF. Hypothermia accompanied by noncardiogenic pulmonary edema: a case report. Del Med J 1996;68:499-502.
28. Gopinathan K, Saroja D, Spears R, et al. Hemodynamic studies in heroin-induced acute pulmonary edema (abstract). Circulation 1970;III:61-3.
29. Dettmeyer R, Schmidt P, Musshoff F, Dreisvogt C, Madea B. Pulmonary edema in fatal heroin overdose: immunohistological investigations with IgE, collagen IV and laminin-no increase of defects of alveolar-capillary membranes. Forensic Sci Int 2000;110:87-96.
30. Sporer KA, Dorn E. Heroin-related noncardiogenic pulmonary edema. Chest 2001:120;1628-32.
31. Sterrett C, Brownfield J, Korn CS, Hollinger M, Henderson SO. Patterns of presentation in heroin overdose resulting in pulmonary edema. Am Emerg Med 2003;21:32-4.
32. Boeuf B, Poirier V, Gauvin F, et al. Naloxone for shock. Cochrane Database Syst Rev 2003
33. De Maria A, Carven DE, Heffernan JJ, McIntosh TK, Grindlinger GA, McCabe WR. Naloxone versus placebo in treatment of septic shock. Lancet 1985;1:1363-5.
34. Safani M, Libby G. Naloxone therapy of septic shock. Crit Care Med 1985;13:875-6.